Evidence map›Paper›PMID 34040519›Full record

ArticleFrontiers in pharmacology2021

Rohit Sharma, Rajesh Bolleddu, Jayanta K Maji, Galib Ruknuddin, Pradeep K Prajapati

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systematic review and meta-analysis ofFrontiers in pharmacology · 2022
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Evaluation of the Antidiabetic Potential of Xanthone-Rich Extracts fromInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Therapeutic Effect ofClinical medicine insights. Endocrinology and diabetes · 2023
    Article
  12. Frontiers in plant science · 2022
    Article
  13. Article
  14. Bioinorganic chemistry and applications · 2022
    Review
  15. In Vivo Anti-Inflammatory, Analgesic, Muscle Relaxant, and Sedative Activities of Extracts fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. The Structural and Thermal properties of Badarashma Pishti.Journal of Ayurveda and integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rohit SharmaDepartment of Ras Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Rajesh BolledduCentral Ayurveda Research Institute, CCRAS, Ministry of AYUSH, Government of India, Kolkata, West Bengal, India.
Jayanta K MajiSociety for Research and Initiatives for Sustainable Technologies and Institutions (SRISTI), Ahmedabad, India.
Galib RuknuddinDepartment of Ras Shastra and Bhaishajya Kalpana, All India Institute of Ayurveda, University of Delhi, New Delhi, India.
Pradeep K PrajapatiDepartment of Ras Shastra and Bhaishajya Kalpana, All India Institute of Ayurveda, University of Delhi, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-hyperglycemicbhavanaguduchihypoglycemictinospora cordifoliaα-amylaseα-glucosidase

Identifiers

PMID34040519
PMCPMC8141809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.